American Journal of Clinical Nutrition, Vol 46, 685-687, Copyright © 1987 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Dietary calcium intake and bone loss from the spine in healthy postmenopausal women

B Dawson-Hughes, P Jacques and C Shipp
USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA 02111.

Controversy exists over the relationship between calcium intake and axial bone loss. We measured bone density of the spine (L2-4) by dual photon absorptiometry (DPA) two times, 7 mo apart, in 76 healthy postmenopausal women aged 40-70 y. Ca intake was assessed by food- frequency questionnaire. Women with a Ca intake less than 405 mg/d lost spine density at a rate that was significantly greater than that of women with an intake greater than 777 mg/d, p = 0.026. There appears to be a threshold of Ca intake below which increased Ca in the diet is likely to be beneficial in reducing spine mineral loss.

This article has been cited by other articles:

				S. L. Greenspan, A. Brufsky, B. C. Lembersky, R. Bhattacharya, K. T. Vujevich, S. Perera, S. M. Sereika, and V. G. Vogel Risedronate Prevents Bone Loss in Breast Cancer Survivors: A 2-Year, Randomized, Double-Blind, Placebo-Controlled Clinical Trial J. Clin. Oncol., June 1, 2008; 26(16): 2644 - 2652. [Abstract] [Full Text] [PDF]

				M. Varenna, L. Binelli, S. Casari, F. Zucchi, and L. Sinigaglia Effects of dietary calcium intake on body weight and prevalence of osteoporosis in early postmenopausal women Am. J. Clinical Nutrition, September 1, 2007; 86(3): 639 - 644. [Abstract] [Full Text] [PDF]

				S. L. Greenspan, J. B. Nelson, D. L. Trump, and N. M. Resnick Effect of Once-Weekly Oral Alendronate on Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: A Randomized Trial Ann Intern Med, March 20, 2007; 146(6): 416 - 424. [Abstract] [Full Text] [PDF]

				S. L. Greenspan, R. K. Bhattacharya, S. M. Sereika, A. Brufsky, and V. G. Vogel Prevention of Bone Loss in Survivors of Breast Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 131 - 136. [Abstract] [Full Text] [PDF]

				S. L. Greenspan, P. Coates, S. M. Sereika, J. B. Nelson, D. L. Trump, and N. M. Resnick Bone Loss after Initiation of Androgen Deprivation Therapy in Patients with Prostate Cancer J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6410 - 6417. [Abstract] [Full Text] [PDF]

				S. L. Greenspan, N. M. Resnick, and R. A. Parker Vitamin D Supplementation in Older Women J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2005; 60(6): 754 - 759. [Abstract] [Full Text] [PDF]

				S. L. Greenspan, N. M. Resnick, and R. A. Parker Early Changes in Biochemical Markers of Bone Turnover Are Associated with Long-Term Changes in Bone Mineral Density in Elderly Women on Alendronate, Hormone Replacement Therapy, or Combination Therapy: A Three-Year, Double-Blind, Placebo-Controlled, Randomized Clinical Trial J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2762 - 2767. [Abstract] [Full Text] [PDF]

				S. C. Ho, Y.-M. Chen, J. L. F. Woo, and S. S. H. Lam High Habitual Calcium Intake Attenuates Bone Loss in Early Postmenopausal Chinese Women: An 18-Month Follow-Up Study J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2166 - 2170. [Abstract] [Full Text] [PDF]

				P. S. Coates, J. D. Fernstrom, M. H. Fernstrom, P. R. Schauer, and S. L. Greenspan Gastric Bypass Surgery for Morbid Obesity Leads to an Increase in Bone Turnover and a Decrease in Bone Mass J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1061 - 1065. [Abstract] [Full Text] [PDF]

				S. L. Greenspan, N. M. Resnick, and R. A. Parker Combination Therapy With Hormone Replacement and Alendronate for Prevention of Bone Loss in Elderly Women: A Randomized Controlled Trial JAMA, May 21, 2003; 289(19): 2525 - 2533. [Abstract] [Full Text] [PDF]